Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) SHH

Currency In CNY

AD

Valuation

Market Cap5.52B
Enterprise Value4.05B
P/E Ratio182.27
PEG Ratio-2.5
Price/Sales Ratio11.82
Price/Book Ratio2.64
Enterprise/Revenue9.32
Enterprise/EBITDA81.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue448.37M
Revenue/Share2.96
Gross Profit448.37M
EBITDA35.47M
Net Income46.8M
Diluted EPS0.32

Balance Sheet

Total Cash1.26B
Total Cash/Share8.15
Total Debt100.18M
Total Debt/Equity0.05
Current Ratio9.51
Book Value Per Share13.82

Price History

52-Week Change-13.5
52-Week High50.98
52-Week Low30.4
Moving Average 50 Days37.64
Moving Average 200 Days37.59

Statistics

Average Volume2.47M
Shares Outstanding149.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.7
Trailing Annual Dividend Yield1.92
Payout Ratio5.99
Last Split FactorN/A
Last Split DateN/A
AD